MedTrace Logo

Effect of Folic Acid and/or Pentoxifylline on Patients With Chronic Kidney Disease

NCT05284656 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2025-06-11

Study results available
· View outcomes & findings →

Summary

The aim of this study is to evaluate the effect of administration of folic acid and /or pentoxifylline on patients with chronic kidney disease (CKD).

Conditions

  • Chronic Kidney Diseases

Interventions

DRUG

combination of Pentoxifylline 400 MG and Folic Acid

drugs used to delay progression of chronic kidney disease

DRUG

folic acid

drugs used to delay progression of chronic kidney disease

DRUG

Pentoxifylline 400 MG

drugs used to delay progression of chronic kidney disease

Sponsors & Collaborators

  • Al-Azhar University

    lead OTHER

Principal Investigators

  • Zeinab AlKasaby · Professor and Head of Clinical Pharmacy Department, Faculty of Pharmacy (Girls), Al-Azhar University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-08
Primary Completion
2026-06-12
Completion
2026-12-19

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05284656 on ClinicalTrials.gov